BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Algernon NeuroScience Appoints Globally Recognized DMT Researcher and Clinician Dr. Sándor Nardai as Principal Investigator for Planned Phase 2a DMT Human Stroke Study

  February 11, 2025

   · 

  6 min read
• Press Releases

  Travere Therapeutics to Submit sNDA for FILSPARI® (sparsentan) in FSGS

  February 11, 2025

   · 

  17 min read
• Press Releases

  Health Canada Approves Merck’s KEYTRUDA® (pembrolizumab) for the treatment of adult patients with resectable Stage II, IIIA, or IIIB (T3-4N2) non-small cell lung carcinoma (NSCLC) in combination with platinum-containing chemotherapy as neoadjuvant treatment, and then continued as monotherapy as adjuvant treatment after surgery

  February 11, 2025

   · 

  7 min read
• Press Releases

  Syantra, Inc. Announces Chair of Scientific Advisory Board and New Members

  February 11, 2025

   · 

  4 min read
• Press Releases

  CareDx to Report Fourth Quarter and Full Year 2024 Financial Results

  February 11, 2025

   · 

  1 min read
• Press Releases

  Navigator Medicines Appoints Tausif ‘Tosh’ Butt as Chief Executive Officer and Khurem Farooq as Chairman of the Board of Directors

  February 11, 2025

   · 

  3 min read
• Press Releases

  Revolo to Present at the 2025 AAAAI / WAO Joint Congress

  February 11, 2025

   · 

  3 min read
• Press Releases

  Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

  February 11, 2025

   · 

  3 min read
• Press Releases

  Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update

  February 11, 2025

   · 

  17 min read
• Press Releases

  Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  February 11, 2025

   · 

  2 min read